My Application Form Status

Check the status of your application form with Angel Broking.
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Cipla gains as foreign brokerage maintains buy rating
Dec 27,2016

Meanwhile, the S&P BSE Sensex was up 110.30 points or 0.43% at 25,917.40.

On the BSE, 51,000 shares were traded on the counter so far as against the average daily volumes of 1.37 lakh shares in the past one quarter. The stock had hit a high of Rs 565.65 and a low of Rs 553.95 so far during the day.

The stock had hit a 52-week high of Rs 660 on 29 December 2015 and a 52-week low of Rs 458.25 on 25 May 2016. It had outperformed the market over the past one month till 26 December 2016, sliding 1.67% compared with the Sensexs 1.94% fall. The scrip had also outperformed the market in past one quarter, declining 8.32% as against the Sensexs 8.79% fall.

The large-cap company has equity capital of Rs 160.88 crore. Face value per share is Rs 2.

On a consolidated basis, Ciplas net profit dropped 34.7% to Rs 354.34 crore on 8.7% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1,000 products across wide range of therapeutic categories with one quality standard globally.

Powered by Capital Market - Live News

Satin Creditcare Network allots NCDs aggregating Rs 15 crore
Dec 27,2016

Satin Creditcare Network has allotted 150 Rated, Unsecured, Senior, Taxable, Non-Convertible Debentures of Rs 10 lakh each aggregating Rs 15 crore on 26 December 2016.

Powered by Capital Market - Live News

Board of Igarashi Motors India defers proposal of reorganisation of business
Dec 27,2016

Igarashi Motors India announced that the Board of Directors of the Company at its meeting held on 26 December 2016 has decided to defer the proposal of re-organisation of business, including amalgamation of group companies, to next board meeting.

Powered by Capital Market - Live News

Bharat Immunologicals & Biological Corporation to announce Q3 results
Dec 27,2016

Bharat Immunologicals & Biological Corporation announced that a meeting of the Board of Directors of the Company is scheduled to be held on 23 January 2017, to approve and take on record the Un-audited Quarterly/Nine months Financial Results of the Company for the quarter/period ended 31 December 2016.

Powered by Capital Market - Live News

Vaibhav Global allots equity shares
Dec 27,2016

Vaibhav Global has allotted 20 Equity Shares of Rs. 10 each on 27 December 2016 to Vaibhav Global Employee Stock Option Welfare Trust under VGL Employee Stock Option Plan (As Amended) - 2006.

Consequent to the said allotment, the paid up Equity Share Capital of the Company has increased to Rs. 32,53,60,850 consisting of 3,25,36,085 Equity Shares of Rs. 10 each.

Powered by Capital Market - Live News

GlaxoSmithKline Pharma to consider Q3 and 9M results
Dec 27,2016

GlaxoSmithKline Pharma will hold a board meeting on 11 February 2017 for approval and declaration of Un-Audited Financial Results for the third quarter and nine months ended 31 December 2016.

Powered by Capital Market - Live News

Capital First gains on fund raising plans
Dec 27,2016

The announcement was made after market hours yesterday, 26 December 2016.

Meanwhile, the S&P BSE Sensex was up 68.50 points or 0.27% at 25,875.60.

On the BSE, 3,887 shares were traded on the counter so far as against the average daily volumes of 38,727 shares in the past one quarter. The stock was volatile. The stock rose as much as 1.79% at the days high of Rs 522.95 so far during the day. The stock rose as much as 0.03% at the days low of Rs 513.90 so far during the day.

The stock had hit a 52-week high of Rs 796.25 on 28 July 2016 and a 52-week low of Rs 348 on 29 February 2016. The stock had underperformed the market over the past one month till 26 December 2016, declining 8.22% compared with the Sensexs 1.94% fall. The scrip had also underperformed the market over the past one quarter falling 26.26% as against the Sensexs 8.79% fall.

The mid-cap company has equity capital of Rs 97.38 crore. Face value per share is Rs 10.

Capital First said that the meeting of the debenture committee of the board of directors of the company will be held on 29 December 2016, to consider the private placement of rated, listed, secured/unsecured/perpetual, redeemable, non-convertible securities in the nature of debentures.

The debentures shall be listed on the debt market segment of National Stock Exchange of India (NSE).

Capital Firsts consolidated net profit rose 40.3% to Rs 57.57 crore on 57.6% rise in net sales to Rs 686.32 crore in Q2 September 2016 over Q2 September 2015.

Capital First is a leading financial institution in India focused on providing debt financing to micro small and medium enterprises (MSME) and Indian consumers.

Powered by Capital Market - Live News

Ind-Ra: Markets to Stay Range Bound
Dec 27,2016

Market activity will stay muted and range bound in the coming week and in absence of any major data releases, says India Ratings and Research (Ind-Ra). The 10-year G-sec yield could trade at 6.46%-6.57% (6.51% at close on 23 November 2016) in the current week. The rupee is likely to trade at 67.6/USD-68.1/USD (67.85/USD at close on 23 November 2016).

Bond Market to Consolidate in Near-term: Following the US Fed rate hike and the Reserve Bank of Indias (RBI) hawkish rhetoric, bond yields surged with the benchmark 10-year hovering around the 6.5% mark. Market is likely to pivot around the existing levels in the near term, with the overall bias towards yields inching higher. An uptick in global yields or a potential surge in crude oil price will keep the domestic debt markets tone cautious.

Rupee to Remain Anchored: Despite the sharp weakness in peers and heavy portfolio outflows in debt and equity markets, the rupee has clawed back and recouped part of the losses following the US election outcome. The rupee strengthened 1.5% from its all-time lows in one month period. Ahead of year end, the rupee is likely to stay anchored at the current levels.

Interbank Liquidity Surplus Continues: The RBI continues to sterilise additional liquidity in the system - through a mix of both reverse repo window and issuance of cash management bills under the market stabilisation scheme. The bills have enabled the RBI to absorb liquidity worth INR4.6 trillion on 16 December 2016. With the official deadline of deposits approaching (31 December 2016), Ind-Ra believes the consequent influx of deposits will keep the system in the surplus mode.

Powered by Capital Market - Live News

Future Enterprises moves higher after exiting Future Lifestyle Fashions
Dec 27,2016

Shares of Future Lifestyle Fashions fell 1.24% at Rs 119.10.

Meanwhile, the S&P BSE Sensex was up 121.75 points or 0.47% at 25,928.85.

On the BSE, 29,000 shares of Future Enterprises were traded on the counter so far as against the average daily volumes of 3.39 lakh shares in the past one quarter. The stock had hit a high of Rs 16.85 and a low of Rs 16 so far during the day.

The stock had hit a 52-week high of Rs 28.55 on 26 May 2016 and a 52-week low of Rs 14.20 on 9 November 2016. It had outperformed the market over the past one month till 26 December 2016, sliding 0.62% compared with the Sensexs 1.94% fall. The scrip had also outperformed the market in past one quarter, advancing 0.94% as against the Sensexs 8.79% fall.

The small-cap company has equity capital of Rs 86.64 crore. Face value per share is Rs 2.

Future Enterprises sold 3.05 crore shares of Future Lifestyle Fashions to Future Corporate Resources at Rs 123 per share in a bulk deal on the NSE yesterday, 26 December 2016. With this transaction, Future Enterprises sold off its entire stake of 16.09% in Future Lifestyle Fashions (holding as on 30 September 2016). Future Corporate Resources held 17.04% stake in Future Lifestyle Fashions as on 30 September 2016.

Future Enterprises reported net loss of Rs 33.85 crore in Q2 September 2016 as against net profit of Rs 32.48 crore in Q2 September 2015. Net sales declined 69.3% to Rs 935.25 crore in Q2 September 2016 over Q2 September 2015.

Future Enterprises is into retail infrastructure business after demerging retail business into Bharti Retail.

Powered by Capital Market - Live News

Bharat Financial Inclusion rises on bargain hunting
Dec 27,2016

Meanwhile, the BSE Sensex was up 106.17 points, or 0.41%, to 25,913.27.

On the BSE, so far 6.28 lakh shares were traded in the counter, compared with average daily volumes of 2.75 lakh shares in the past one quarter. The stock had hit a high of Rs 495.60 and a low of Rs 465.40 so far during the day.

The stock hit a 52-week high of Rs 938.75 on 29 July 2016. The stock hit a 52-week low of Rs 435 on 21 January 2016. The stock had underperformed the market over the past 30 days till 26 December 2016, falling 31.29% compared with the 1.94% fall in the Sensex. The scrip had also underperformed the market in past one quarter, falling 43.88% as against Sensexs 8.56% decline.

The mid-cap company has equity capital of Rs 137.93 crore. Face value per share is Rs 10.

Shares of Bharat Financial Inclusion fell 27.15% in seven trading sessions to settle at Rs 480.45 yesterday, 26 December 2016, from its close of Rs 659.55 on 15 December 2016.

Bharat Financial Inclusions net profit rose 87.4% to Rs 145.88 crore on 37.4% increase in operating income to Rs 411.37 crore in Q2 September 2016 over Q2 September 2015.

Bharat Financial Inclusion is among the largest microfinance companies in India.

Powered by Capital Market - Live News

Great Eastern Shipping Company contracts to buy a Suezmax Crude Carrier
Dec 27,2016

Great Eastern Shipping Company has signed a contract to buy a Suezmax Crude Carrier of about 150000 dwt. The 2000 built vessel is expected to join the Companys fleet in Q4 FY 2017.

Powered by Capital Market - Live News

Great Eastern Shipping Company contracts to buy a Suezmax Crude Carrier
Dec 27,2016

Great Eastern Shipping Company has signed a contract to buy a Suezmax Crude Carrier of about 150000 dwt. The 2000 built vessel is expected to join the Companys fleet in Q4 FY 2017.

Powered by Capital Market - Live News

Board of Ahluwalia Contracts (India) to consider preferential issue of shares
Dec 27,2016

Ahluwalia Contracts (India) announced that a meeting of the Board of Directors of the Company will be held on 09 January 2017, to consider the proposal for issue of further shares to one of the Promoters on preferential allotment basis.

Powered by Capital Market - Live News

Board of Ahluwalia Contracts (India) to consider preferential issue of shares
Dec 27,2016

Ahluwalia Contracts (India) announced that a meeting of the Board of Directors of the Company will be held on 09 January 2017, to consider the proposal for issue of further shares to one of the Promoters on preferential allotment basis.

Powered by Capital Market - Live News

Divis Lab gains on bargain hunting
Dec 27,2016

Meanwhile, the BSE Sensex was up 109.81 points, or 0.43%, to 25,916.91.

On the BSE, so far 2.97 lakh shares were traded in the counter, compared with average daily volumes of 90,758 shares in the past one quarter. The stock had hit a high of Rs 786.50 and a low of Rs 761 so far during the day.

The stock hit a record high of Rs 1,380 on 16 September 2016. The stock hit a 52-week low of Rs 745 on 26 December 2016. The stock had underperformed the market over the past 30 days till 26 December 2016, falling 33.86% compared with the 1.94% fall in the Sensex. The scrip had also underperformed the market in past one quarter, falling 42.20% as against Sensexs 8.56% decline.

The large-cap company has equity capital of Rs 53.09 crore. Face value per share is Rs 2.

Shares of Divis Laboratories fell 33.28% in three trading sessions to settle at Rs 765.30 yesterday, 26 December 2016, from its close of Rs 1,147.10 on 21 December 2016.

The recent slump was triggered by media reports of adverse observations from the US drug regulator made on its Vizag facility in Andhra Pradesh.

Shares of Divis Laboratories slumped 21.87% to Rs 866.10 on Friday, 23 December 2016, following media reports of adverse observations from the US Food and Drug Administration (USFDA) made on its Vizag facility in Andhra Pradesh. Divis Laboratories is in the process of replying to the observations raised by USFDA. Due process of reply to these observations requires Divis Laboratories to respond in detail and this is being done in time, the company said in a response to the clarification sought by the stock exchanges on the steep fall. These observations have not impacted the companys operations, the company added. USFDA inspected the Unit-2 plant from 29 November 2016 to 6 December 2016 and issued a Form 483 with five observations pertaining to breaches in data integrity, improper controls and violations of current good manufacturing practices (cGMP). The company issued the clarification after market hours on Friday, 23 December 2016.

The stock fell 30.97% in two trading sessions to settle at Rs 765.30 yesterday, 26 December 2016, from its close of Rs 1,108.60 on Thursday, 22 December 2016.

Divis Laboratories net profit fell 24.6% to Rs 223.85 crore on 3.11% growth in net sales to Rs 991.82 crore in Q2 September 2016 over Q2 September 2015.

Divis Laboratories is primarily engaged in the manufacture of active pharmaceutical ingredients (APIs) & intermediates for generics, custom synthesis of APIs and advanced intermediates for discovery compounds for pharma giants, building blocks for peptides, building blocks for nucleotides, carotenoids and chiral ligands.

Powered by Capital Market - Live News